Transcarent vs Upside (2026)
Two products a health plan buys for the same member and for entirely different reasons. Transcarent navigates, reaching more than twenty million members with generative guidance across benefits, clinical questions and care access, and publishing better governance material than most of this index. Upside addresses housing instability, which is the kind of barrier no navigation product resolves by routing, with licensed social workers executing every action so the oversight is structural rather than described. A member who cannot keep stable housing will not use the care a navigator finds them, which is the honest relationship between these two. Upside handles housing, financial and social data with no published stewardship terms at all, which is the gap to close before deployment.
- It is bought by employers and health plans, reaching more than twenty million members with navigation across benefits, clinical guidance and care access.
- The governance disclosure is among the better ones in this index, with certifications described precisely and a named accountable owner.
- For a member who does not know where to start, one navigation experience covering benefits and care is the more useful product.
- It addresses housing instability specifically, which is a driver of avoidable utilisation that no navigation product can resolve by routing.
- Oversight is structural by design, since a licensed social worker or housing specialist executes every action rather than an agent acting alone.
- Outcome claims are specific and tied to a defined window rather than asserted generally.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Transcarent and Upside are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Transcarent | Upside |
|---|---|---|
| Primary category | Healthcare Administrative Automation | Value Based Care Intelligence |
| Founded | Not recorded | 2020 |
| Headquarters | San Francisco, California | Fort Lauderdale, Florida |
| Website | transcarent.com | joinupside.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for Transcarent on any axis it scores. Set against Upside, Transcarent grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Upside its top capability grade on Setting and Specialty Coverage. Set against Transcarent, Upside grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Liability and Recourse. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Transcarent or Upside?
On the axes where the AI Health Index separates them, Transcarent grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture, and Upside grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Liability and Recourse. Transcarent leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Transcarent and Upside differ most?
The widest separation the AI Health Index records between Transcarent and Upside is on Model Supply Chain Disclosure, where Transcarent grades B and Upside grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Transcarent and Upside grade the same?
The AI Health Index grades Transcarent and Upside the same on several axes, including AI Centrality, Clinical and Operational Evidence and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Transcarent and Upside not disclosed?
At the last review, at least one of Transcarent and Upside published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Value Based Care Intelligence page.
These are complementary rather than competing, since one routes a member to care and the other removes a barrier that makes care unusable, and a plan may need both. Upside publishes no business associate statement, stewardship framework, retention position or security attestation while handling housing, financial and social data that is more sensitive in some respects than clinical data. Transcarent added agentic capabilities in January 2026 with no published escalation criteria or oversight design, and navigation that acts is a different product from navigation that informs.